Previous 10 | Next 10 |
2023-10-17 14:18:15 ET Are you looking for the best penny stocks to buy now ? Today might be your day…or not. These high-flying, low-priced stocks are well known for their innate ability to explode within a matter of minutes at times. Imagine seeing a stock that trades for pe...
2023-10-16 15:55:39 ET More on Revolution Medicines Revolution Medicines: A Big Pipeline In Need Of Big Data Revolution Medicines' Strategic Edge In RAS-Driven Oncology Revolution Medicines, Inc. (RVMD) Q2 2023 Earnings Call Transcript Revolution Medicines st...
2023-10-13 15:00:54 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
2023-10-13 14:54:35 ET Shares of Revolution Medicines (NASDAQ: RVMD) were up more than 20% as of 2 p.m. ET after the company announced positive phase 1/1b trial data for two cancer therapies. The clinical-stage biotech's stock is up more than 22% so far this year. Revolution...
2023-10-13 14:01:47 ET More on Revolution Medicines Revolution Medicines: A Big Pipeline In Need Of Big Data Revolution Medicines' Strategic Edge In RAS-Driven Oncology Revolution Medicines, Inc. (RVMD) Q2 2023 Earnings Call Transcript Revolution Medicines wi...
Clinical dose escalation data for RMC-6236, a RAS MULTI (ON) Inhibitor, show oral bioavailability, well-tolerated safety profile and preliminary evidence of anti-tumor activity across multiple RAS mutations First clinical data presentation for RMC-6291, a RAS G12C ...
Interim Data to be Presented for RMC-6236 (RAS MULTI (ON) Inhibitor) and RMC-6291 (RAS G12C (ON) Inhibitor) Company to Host Investor Webcast Following ESMO Data Presentation on October 22 at 12:30 p.m. Eastern REDWOOD CITY, Calif., Oct. 04, 2023 (GLOBE ...
2023-09-28 16:18:43 ET More on Mirati Therapeutics Mirati: Expansion Of Adagrasib With sNDA And Combination Studies Mirati Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation Mirati Therapeutics, Inc. (MRTX) Q2 2023 Earnings Call Transcript Mira...
2023-09-25 15:24:12 ET Summary Revolution Medicines, Inc. has a diversified pipeline of drugs but is still searching for its flagship project, making it a high-risk investment. The company is focusing on developing RAS(ON) inhibitors, which target the active form of KRAS, with sev...
2023-09-25 09:00:00 ET Summary Revolution Medicines boasts a strong cash position of $909.5M and a focus on RAS-targeted oncology but faces increased expenses and high clinical expectations. Upcoming clinical data for RMC-6236 and the EQRx acquisition are key catalysts that could ...
News, Short Squeeze, Breakout and More Instantly...
Revolution Medicines Inc. Company Name:
RVMD Stock Symbol:
NASDAQ Market:
Revolution Medicines Inc. Website:
2024-07-14 06:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Original research published in Cancer Discovery reveals a RAS(ON) multi-selective inhibitor exhibited robust anti-tumor activity alone or in combination with a RAS(ON) G12C-selective inhibitor in preclinical models of difficult-to-treat KRAS-mutated non-small cell lung cancer (NSCLC) Re...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) fell 9.3% to $0.2448 on volume of 58,139,351 shares NVIDIA Corporation (NVDA) rose 2.9% to $131.9 on volume of 38,975,630 shares Soligenix Inc. (SNGX) rose 189.2% to $5.784 on volume of 36,915,609...